Futura Medical PLC (AIM:FUM, OTC:FAMDF, FRA:GYX) said its stronger Eroxon Intense erectile dysfunction gel has been cleared for launch across the European Economic Area and UK, widening the group’s flagship consumer-health franchise. The clearance follows the completion of design, validation...

Despite a challenging financial year, Futura Medical PLC (FAMDF) outlines a robust strategy for future growth with new product launches and strengthened partnerships.

MedPal AI plc (AIM:MPAL) has picked up a pharmacy facility in Runcorn for £310,000 from administrators. The site dispensed a million prescription items last year, worth around £10 million in turnover. Futura Medical PLC (AIM:FUM, OTC:FAMDF, FRA:GYX) is shifting its Eroxon business from pure licensing toward a hybrid model with direct sales. It's also progressing two development projects, Eroxon Intense and the WSD4000 female sexual health platform. Solvonis Therapeutics PLC (LSE:SVNS) is pushing its alcohol use disorder drug SVN-001 into phase III trials rather than doing an early licensing deal. The board thinks the asset is worth more after a successful trial than before one. Ecora Royalties PLC (LSE:ECOR, TSX:ECOR, OTCQX:ECRAF, FRA:HGR) more than doubled its portfolio contribution to $12.3 million in the first quarter. Cobalt and copper drove the gains, with Voisey's Bay alone delivering $3.6 million. Arrow Exploration Corp (TSX-V:AXL, AIM:AXL, OTC:CSTPF) grew production 13% in 2025, but profit dropped sharply after a $7.6 million impairment charge. The 2026 drilling programme is fully funded at $24 million with up to nine new wells planned. London BTC Company Ltd (LSE:BTC, OTCQB:VINZF) is adding gold exploration to its Bitcoin mining business, launching in Nevada and Arizona. The plan is to funnel any gold profits straight back into buying more Bitcoin. Follow us and subscribe on YouTube, our social channels, and on proactiveinvestors.co.uk.